Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Luca Stingeni and Gabriella Fabbrocini.
Luca Stingeni
Connection Strength
1.576
Gabriella Fabbrocini
  1. Dupilumab in adolescents with moderate to severe atopic dermatitis: a 32-week real-world experience during the COVID-19 pandemic. Clin Exp Dermatol. 2022 01; 47(1):165-167.
    View in: PubMed
    Score: 0.241
  2. Atopic dermatitis in adolescents: Effectiveness and safety of dupilumab in a 16-week real-life experience during the COVID-19 pandemic in Italy. Dermatol Ther. 2021 09; 34(5):e15035.
    View in: PubMed
    Score: 0.238
  3. Skin rashes after SARS-CoV-2 vaccine: which relationship, if any? Immun Inflamm Dis. 2021 09; 9(3):622-623.
    View in: PubMed
    Score: 0.238
  4. Adverse cutaneous and mucous reactions from anti SARS-CoV-2 vaccines: recommendations from the Italian Society of Dermatology (SIDeMaST). Ital J Dermatol Venerol. 2021 Apr; 156(2):115-117.
    View in: PubMed
    Score: 0.234
  5. SARS-CoV-2 vaccines and biological treatments: dermatological perspectives. Ital J Dermatol Venerol. 2021 Apr; 156(2):118-120.
    View in: PubMed
    Score: 0.234
  6. Management of patients with atopic dermatitis undergoing systemic therapy during COVID-19 pandemic in Italy: Data from the DA-COVID-19 registry. Allergy. 2021 06; 76(6):1813-1824.
    View in: PubMed
    Score: 0.058
  7. Characteristic of chronic plaque psoriasis patients treated with biologics in Italy during the COVID-19 Pandemic: Risk analysis from the PSO-BIO-COVID observational study. Expert Opin Biol Ther. 2021 02; 21(2):271-277.
    View in: PubMed
    Score: 0.058
  8. Hidradenitis suppurativa and adalimumab in the COVID-19 era. Eur J Dermatol. 2020 Dec 01; 30(6):748-749.
    View in: PubMed
    Score: 0.057
  9. Management of biological therapies for chronic plaque psoriasis during COVID-19 emergency in Italy. J Eur Acad Dermatol Venereol. 2020 Dec; 34(12):e770-e772.
    View in: PubMed
    Score: 0.056
  10. The role of occupational dermatology in the COVID-19 outbreak. Contact Dermatitis. 2020 08; 83(2):174-175.
    View in: PubMed
    Score: 0.055
  11. Dupilumab and COVID-19: What should we expect? Dermatol Ther. 2020 Jul; 33(4):e13502.
    View in: PubMed
    Score: 0.055
  12. HIDRAdisk: validation of an innovative visual tool to assess the burden of hidradenitis suppurativa. J Eur Acad Dermatol Venereol. 2019 Apr; 33(4):766-773.
    View in: PubMed
    Score: 0.051
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.